We would never accept this. And yet.

Nobody ends up with forty prescriptions because they stopped believing. They end up with forty prescriptions because each one, briefly, sounded like the last one they would ever need.

Imagine you are unwell.

Not acutely, dramatically unwell. Chronically, persistently, exhaustingly unwell. The kind of unwell that doesn’t resolve itself and doesn’t kill you but quietly diminishes everything.

You seek help. The first doctor is compelling. Credentialled. Certain. The diagnosis sounds right. The treatment plan sounds right. You leave with something that feels, for the first time in a long time, like hope.

Six months later you are back.

You see another doctor. Also compelling. Also certain. A different diagnosis. A different treatment. Also sounds right. You leave again with something that feels like hope.

You do this forty times.

Each doctor genuinely believes in their diagnosis. Each treatment was genuinely tried. The hope was genuine every single time.

And yet here you are. Still unwell. More confused than when you started. And now carrying something worse than the original condition — the creeping suspicion that nobody actually knows what’s wrong.

That is what the transformation market has done to the NHS.

Not through malice. Through the oldest dynamic in any market where desperation meets a convincing pitch.

The miracle weight loss pill has been available, in various formulations, for about a century. It has never worked. It keeps selling because the people buying it are not stupid — they are hopeful. And hope, in a person who has tried everything and is still struggling, is not a weakness. It is entirely rational. The pill might work. This doctor might be different. This supplier might be the one.

The transformation market has understood this for years.

Every supplier walks in with a cure. The slide deck is always impressive. The case studies are always compelling. The certainty is always absolute. And somewhere in the back of every NHS leader’s mind, after years of plans that didn’t land and programmes that quietly dissolved, is the thought that maybe this one is different.

It rarely is. But the pitch was built for exactly that moment of openness. For the exhausted system that still, against all evidence, wants to believe.

That is not a supplier problem. That is the most sophisticated sales environment in the world — one where the buyer’s desperation and the seller’s conviction have found each other and learned to perform a very convincing dance.

Here is what the forty doctors never asked.

You know your own body. Not in the clinical sense — in the way that actually matters. You know what normal feels like. You know when something isn’t right. You know what outcome you want even when you struggle to articulate it in the language being asked for.

The people inside the NHS know this too.

The ward manager knows where the pressure lives. The workforce director knows which numbers don’t add up. The CEO knows which conversation the executive team keeps not having. The board knows which plan it just approved that nobody privately believes.

The problem was never ignorance. It was a question that was never sharp enough to make the answer unavoidable.

And when the question isn’t clear enough, the market does what markets do. It manufactures options. Because options are easy to generate and answers are hard to be accountable for.

The noise isn’t diversity of thought. It’s avoidance of decision.

The NHS has been receiving forty diagnoses a year for two decades. The problems those diagnoses were meant to solve are still there. The treatments have been consumed, forgotten, and replaced by the next round.

The market that produced them has grown larger, not smaller.

A chronically ill patient who sees forty doctors doesn’t have a doctor problem. They have a question problem. The question was never sharp enough to collapse the options into an answer.

And here is the part that should be genuinely uncomfortable.

The NHS didn’t end up with forty diagnoses because the market failed to understand the problem.

It ended up with forty diagnoses because a clear question would have made someone accountable for the answer.

Accountability, in a system this complex, with this many stakeholders and this much political exposure, is the thing everyone has become most sophisticated at avoiding. Every new solution, every new framework lot, every new roundtable is another way of deferring the moment when someone stands up and says: this is the problem, this is what we are doing about it, and this is what we are prepared to stop doing until it’s solved.

A market that selects for performance over truth will always produce more options than outcomes. Because performance scales. Accountability doesn’t.

The answer isn’t a better shortlist from the forty on offer.

It’s a question so clear that thirty-seven of them fall away on contact.

What are we actually trying to fix?

In the language of the ward manager who knows where the pressure lives. In the numbers the workforce director knows don’t add up. In the conversation nobody is having out loud.

When the question is that sharp, the answer moves from debate to decision.

Most of the forty were never answering your question. They were answering the question they wished you’d asked. The one their cure fits.

The miracle pill keeps selling because the question was never “does this work?”

It was “please let this be the one.”

The diagnosis isn’t hiding in forty slide decks.

It’s already in the room. It has been for years.

Disclaimer: This information is provided for general guidance only. It may not reflect the most up-to-date NHS policies or local Trust practices. Always refer to current NHS guidance and your organisation’s policies for definitive information.